Q2 2025 Holdings
Filed 2025-08-14 | 57 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $208.9M | 268,023 | 17.8% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $87.9M | 499,243 | 7.5% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $53.0M | 72,313 | 4.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $50.4M | 483,105 | 4.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $48.3M | 88,967 | 4.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $42.7M | 166,261 | 3.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $38.3M | 221,754 | 3.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $34.1M | 407,202 | 2.9% |
| CVS Health Corp(CVS) | COM | 126650100 | $33.0M | 479,005 | 2.8% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $32.0M | 1,664,727 | 2.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $31.9M | 161,413 | 2.7% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $30.7M | 392,503 | 2.6% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $28.8M | $23,000,000 | 2.5% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $27.7M | 72,290 | 2.4% |
| Humana Inc(HUM) | COM | 444859102 | $26.8M | 109,511 | 2.3% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $25.5M | 85,739 | 2.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $23.6M | 72,220 | 2.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $22.5M | 521,793 | 1.9% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $20.8M | 1,238,846 | 1.8% |
| Unitedhealth Group Inc(UNH)Put | COM | 91324P102 | $20.3M | 65,000 | 1.7% |
| Indivior PLC(INDV) | ORD | G4766E116 | $20.0M | 1,355,931 | 1.7% |
| Natera Inc(NTRA) | COM | 632307104 | $17.1M | 101,250 | 1.5% |
| Cencora Inc(COR) | COM | 03073E105 | $16.0M | 53,287 | 1.4% |
| Masimo Corp(MASI) | COM | 574795100 | $15.9M | 94,451 | 1.4% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $15.8M | 735,033 | 1.3% |
| Waters Corp(WAT) | COM | 941848103 | $15.0M | 43,089 | 1.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $14.2M | 266,167 | 1.2% |
| Hologic Inc(HOLX) | COM | 436440101 | $13.8M | 211,986 | 1.2% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $13.6M | 88,157 | 1.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $12.9M | 923,375 | 1.1% |
| Icon PLC(ICLR) | SHS | G4705A100 | $12.8M | 88,181 | 1.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $10.8M | 34,623 | 0.9% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $10.6M | 17,129 | 0.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $10.5M | 36,391 | 0.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.8M | 178,319 | 0.8% |
| Merus N V | COM | N5749R100 | $9.7M | 183,882 | 0.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $7.6M | 80,416 | 0.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $7.6M | 40,782 | 0.6% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $6.2M | 48,444 | 0.5% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $5.6M | 770,038 | 0.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.0M | 1,779,259 | 0.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $4.7M | 732,256 | 0.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.5M | 344,972 | 0.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.0M | 7,237 | 0.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $3.6M | 84,713 | 0.3% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $3.5M | 244,261 | 0.3% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $2.7M | 1,972,073 | 0.2% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.4M | 174,331 | 0.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.9M | 434,134 | 0.2% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $1.7M | 1,358,831 | 0.1% |